A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer

Figure 7

Construction of a predictive nomogram. (a) The nomogram for predicting the OS of patients with GC at 1, 2, and 3 years. (b) Calibration curves of the nomogram for OS prediction at 1, 2, and 3 years. (c) ROC curves to evaluate the predictive ability of the nomogram.

(a)

(b)

(c)